Argenx
ARGX
#483
Rank
NZ$87.21 B
Marketcap
NZ$1,396
Share price
-0.30%
Change (1 day)
43.49%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company